Apheresis product total CD34+ cell count prediction at peripheral stem cell collection via a formula: A multicenter study
Transplant Immunology · 2024
DOI: 10.1016/j.trim.2024.102111 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Transplant Immunology, 2024. Verfasst von Murat Yildirim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Gülhane Education and Research Hospital, Department of Hematology and Bone Barrow Transplantation Unit, Ankara, Turkiye. Hauptthemen laut MEDLINE: Antigens, CD34, Hematopoietic Stem Cell Mobilization, Peripheral Blood Stem Cells, Blood Component Removal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: Effective mobilization of Stem Cells(SCs) to peripheral blood (PB) is crucial for obtaining sufficient CD34+ cell numbers via apheresis. The ratio of pre-apheresis PB CD34+ cells is the best parameter for predicting the product CD34+ cell count. However, quantitating CD34+ PB cells requires flow cytometry, which usually takes two or more hours to obtain the results. We hypothesized that the product CD34+ cell count could be predicted using the counts of white blood cells (WBCs), mononuclear cells (MNCs), and pre-apheresis CD34+ cells. A formula that achieves this would substantially affect the efficiency and effectiveness of apheresis. We, therefore, aimed to estimate the number of CD34+ cells in the product using a formula that incorporates pre-apheresis PB WBC, MNC, and CD34+ cell counts and product WBC and MNC counts. METHODS: We examined the results of 373 leukapheresis procedures for SC mobilization. Effective separation of CD34+ PBSCs (count/μL) via apheresis was estimated using the following formula: [Product WBC (count/μL) × MNC (count/μL) × pre-apheresis CD34+ cell (percentage/μL)] ÷ [PB WBC count/μL × PB MNC (count/μL)]. RESULTS: A strong correlation was observed between the CD34+ cell count calculated using our formula and the post-apheresis CD34+ cell count measured via flow cytometry (R = 0.939, based on linear regression analysis). In the subgroup analysis, this correlation was observed for all the disease subgroups and healthy donors. CONCLUSION: We developed a formula that predicts the product CD34+ cell count and is useful for determining whether a second apheresis procedure will be required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gülhane Education and Research Hospital, Department of Hematology and Bone Barrow Transplantation Unit, Ankara, Turkiye.
- Gülhane Education and Research Hospital, Department of Hematology and Bone Barrow Transplantation Unit, Ankara, Turkiye. Electronic address: sayinselim@hotmail.com.
- Ankara Memorial Hospital Department of Hematology and Bone Barrow Transplantation Unit, Ankara, Turkiye.
- Bayındır Sögütözü Hospital Department of Hematology and Bone Barrow Transplantation Unit, Ankara, Turkiye.
Zitieren
APA
Yildirim, M., Sayin, S., Ertas, Z., Ayyildiz, E., Aksoyoglu, I., Avcu, F., Ural, A. U., & Ayli, M. (2024). Apheresis product total CD34+ cell count prediction at peripheral stem cell collection via a formula: A multicenter study. Transplant Immunology. https://doi.org/10.1016/j.trim.2024.102111
Vancouver
Yildirim M, Sayin S, Ertas Z, Ayyildiz E, Aksoyoglu I, Avcu F, et al. Apheresis product total CD34+ cell count prediction at peripheral stem cell collection via a formula: A multicenter study. Transplant Immunology. 2024. doi:10.1016/j.trim.2024.102111
BibTeX
@article{Yildirim2024,
author = {Yildirim, Murat and Sayin, Selim and Ertas, Zerrin and Ayyildiz, Erol and Aksoyoglu, Ilknur and Avcu, Ferit and Ural, Ali Ugur and Ayli, Meltem},
title = {Apheresis product total CD34+ cell count prediction at peripheral stem cell collection via a formula: A multicenter study},
journal = {Transplant Immunology},
year = {2024},
doi = {10.1016/j.trim.2024.102111}
}
EUVIMED